Anhui Huaren Health Pharmaceutical's (SZSE:301408) Weak Earnings May Only Reveal A Part Of The Whole Picture
May 07
Chinese (SSE) Drug Retail Industry Analysis
UpdatedMay 09, 2024
DataAggregated Company Financials
Companies9
- 7D2.7%
- 3M2.8%
- 1Y-5.4%
- YTDn/a
In the last week, the Drug Retail industry is up 2.7%, with all of the companies up. However, the industry is down 5.4% over the past year. As for the next few years, earnings are expected to grow by 21% per annum.
Industry Valuation and Performance
Has the Chinese Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 10 May 2024 | CN¥125.6b | CN¥118.2b | CN¥4.8b | 26.6x | 26.3x | 1.1x |
| Sun, 07 Apr 2024 | CN¥116.0b | CN¥114.8b | CN¥5.2b | 21.5x | 22.2x | 1x |
| Tue, 05 Mar 2024 | CN¥115.6b | CN¥115.9b | CN¥5.8b | 19.9x | 19.9x | 1x |
| Thu, 01 Feb 2024 | CN¥113.1b | CN¥116.0b | CN¥5.7b | 20.2x | 19.7x | 1x |
| Sat, 30 Dec 2023 | CN¥128.1b | CN¥116.0b | CN¥5.7b | 22x | 22.3x | 1.1x |
| Mon, 27 Nov 2023 | CN¥130.6b | CN¥116.0b | CN¥5.7b | 22.8x | 22.8x | 1.1x |
| Wed, 25 Oct 2023 | CN¥109.7b | CN¥113.6b | CN¥5.7b | 21.1x | 19.3x | 1x |
| Fri, 22 Sep 2023 | CN¥120.8b | CN¥113.6b | CN¥5.7b | 23.7x | 21.3x | 1.1x |
| Sun, 20 Aug 2023 | CN¥130.2b | CN¥109.7b | CN¥5.4b | 28.1x | 23.9x | 1.2x |
| Tue, 18 Jul 2023 | CN¥126.6b | CN¥109.7b | CN¥5.4b | 26.8x | 23.3x | 1.2x |
| Thu, 15 Jun 2023 | CN¥137.2b | CN¥109.7b | CN¥5.4b | 29.2x | 25.2x | 1.3x |
| Sat, 13 May 2023 | CN¥132.9b | CN¥109.7b | CN¥5.4b | 27.6x | 24.4x | 1.2x |
| Mon, 10 Apr 2023 | CN¥146.5b | CN¥94.8b | CN¥4.4b | 39.7x | 33.6x | 1.5x |
| Wed, 08 Mar 2023 | CN¥142.3b | CN¥90.3b | CN¥4.0b | 34.7x | 35.4x | 1.6x |
| Fri, 03 Feb 2023 | CN¥141.7b | CN¥90.3b | CN¥4.0b | 35.3x | 35.2x | 1.6x |
| Sun, 01 Jan 2023 | CN¥146.6b | CN¥90.3b | CN¥4.0b | 36.8x | 36.4x | 1.6x |
| Tue, 29 Nov 2022 | CN¥150.0b | CN¥90.3b | CN¥4.0b | 37.8x | 37.3x | 1.7x |
| Thu, 27 Oct 2022 | CN¥130.7b | CN¥85.7b | CN¥3.8b | 40x | 34.1x | 1.5x |
| Sat, 24 Sep 2022 | CN¥106.8b | CN¥85.6b | CN¥3.8b | 33.4x | 28x | 1.2x |
| Mon, 22 Aug 2022 | CN¥116.5b | CN¥81.5b | CN¥3.7b | 37.1x | 31.5x | 1.4x |
| Wed, 20 Jul 2022 | CN¥115.2b | CN¥80.8b | CN¥3.7b | 37.9x | 30.9x | 1.4x |
| Fri, 17 Jun 2022 | CN¥107.1b | CN¥80.8b | CN¥3.7b | 34x | 28.7x | 1.3x |
| Sun, 15 May 2022 | CN¥97.1b | CN¥80.8b | CN¥3.7b | 29.8x | 26x | 1.2x |
| Tue, 12 Apr 2022 | CN¥92.9b | CN¥75.3b | CN¥4.1b | 25.5x | 22.9x | 1.2x |
| Thu, 10 Mar 2022 | CN¥106.5b | CN¥74.7b | CN¥4.1b | 29.8x | 26.1x | 1.4x |
| Sat, 05 Feb 2022 | CN¥118.6b | CN¥74.7b | CN¥4.1b | 34.3x | 29.1x | 1.6x |
| Mon, 03 Jan 2022 | CN¥137.5b | CN¥74.7b | CN¥4.1b | 38.7x | 33.7x | 1.8x |
| Wed, 01 Dec 2021 | CN¥123.1b | CN¥74.7b | CN¥4.1b | 32x | 30.2x | 1.6x |
| Fri, 29 Oct 2021 | CN¥120.5b | CN¥72.9b | CN¥4.1b | 28.8x | 29.7x | 1.7x |
| Sun, 26 Sep 2021 | CN¥125.0b | CN¥72.0b | CN¥4.2b | 30.9x | 30x | 1.7x |
| Tue, 24 Aug 2021 | CN¥139.9b | CN¥72.0b | CN¥4.2b | 32.4x | 33.6x | 1.9x |
| Wed, 30 Jun 2021 | CN¥135.3b | CN¥67.1b | CN¥3.9b | 32.9x | 34.4x | 2x |
Price to Earnings Ratio
41.6x
Current Industry PE
- Investors are relatively neutral on the Chinese Drug Retail industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 28.7x.
- The 3-year average PS ratio of 1.4x is higher than the industry's current PS ratio of 1.1x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have grown 7.8% per year over the last three years.
- Revenues for these companies have grown 22% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Chinese Drug Retail compare with similar industries?
| CN Market | 0.95% | |
| Consumer Staples | 2.86% | |
| Food and Staples Retail | 2.27% | |
| Drug Retail | 2.67% | |
| Food Distributors | 3.92% | |
| Food Retail | 1.95% | |
| Big Box Super Stores | 1.36% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603939 Yifeng Pharmacy Chain | CN¥46.63 | 6.1% +CN¥2.7b | 29.8% | PE31.8x | |
| 603883 LBX Pharmacy Chain | CN¥35.80 | 7.0% +CN¥1.4b | 7.8% | PE21.8x | |
| 603233 DaShenLin Pharmaceutical Group | CN¥22.86 | 5.0% +CN¥1.2b | -16.9% | PE24.4x | |
| 2727 Yixintang Pharmaceutical Group | CN¥22.16 | 5.1% +CN¥643.7m | -20.6% | PE23.9x | |
| 605266 Jianzhijia Pharmaceutical Chain Group | CN¥50.62 | 6.0% +CN¥371.1m | -13.4% | PE16.7x |
